Search research articles
Contact Us
Filters
Showing results (711-720 of 903) with videos related to
Page
of 91
Sort By:
Brain Communications
|
October 7, 2021
Amyloid-driven disruption of default mode network connectivity in cognitively healthy individuals
Silvia Ingala, Jori Tomassen, Lyduine E Collij, et al.
Journal of Neurology
|
July 4, 2019
Prognostic value of Alzheimer's biomarkers in mild cognitive impairment: the effect of age at onset
Daniele Altomare, Clarissa Ferrari, Anna Caroli, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
April 26, 2011
The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Guy M McKhann, David S Knopman, Howard Chertkow, et al.
Frontiers in Aging Neuroscience
|
February 15, 2019
Amyloid-β Load Is Related to Worries, but Not to Severity of Cognitive Complaints in Individuals With Subjective Cognitive Decline: The SCIENCe Project
Sander C J Verfaillie, Tessa Timmers, Rosalinde E R Slot, et al.
Alzheimer'S Research & Therapy
|
April 17, 2019
Personalized risk for clinical progression in cognitively normal subjects-the ABIDE project
Ingrid S van Maurik, Rosalinde E R Slot, Sander C J Verfaillie, et al.
Journal of Alzheimer'S Disease : JAD
|
January 17, 2022
Psychosocial Effects of COVID-19 Measures on (Pre-)Dementia Patients During Second Lockdown
Els D Bakker, Ingrid S van Maurik, Arenda Mank, et al.
Brain : a Journal of Neurology
|
October 21, 2022
Social cognition deficits and biometric signatures in the behavioural variant of Alzheimer's disease
Ellen H Singleton, Jay L P Fieldhouse, Jochum J van 't Hooft, et al.
Neurobiology of Aging
|
April 27, 2019
Amyloid PET and cognitive decline in cognitively normal individuals: the SCIENCe project
Tessa Timmers, Rik Ossenkoppele, Sander C J Verfaillie, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
April 5, 2021
White matter microstructure disruption in early stage amyloid pathology
Lyduine E Collij, Silvia Ingala, Herwin Top, et al.
Alzheimer'S Research & Therapy
|
May 14, 2016
Bapineuzumab for mild to moderate Alzheimer's disease in two global, randomized, phase 3 trials
Rik Vandenberghe, Juha O Rinne, Mercè Boada, et al.
Page
of 91
Search research articles
Search
Showing results (711-720 of 903) with videos related to
Sort By:
Page
of 91
Brain Communications
|
October 7, 2021
Amyloid-driven disruption of default mode network connectivity in cognitively healthy individuals
Silvia Ingala, Jori Tomassen, Lyduine E Collij, et al.
Journal of Neurology
|
July 4, 2019
Prognostic value of Alzheimer's biomarkers in mild cognitive impairment: the effect of age at onset
Daniele Altomare, Clarissa Ferrari, Anna Caroli, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
April 26, 2011
The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Guy M McKhann, David S Knopman, Howard Chertkow, et al.
Frontiers in Aging Neuroscience
|
February 15, 2019
Amyloid-β Load Is Related to Worries, but Not to Severity of Cognitive Complaints in Individuals With Subjective Cognitive Decline: The SCIENCe Project
Sander C J Verfaillie, Tessa Timmers, Rosalinde E R Slot, et al.
Alzheimer'S Research & Therapy
|
April 17, 2019
Personalized risk for clinical progression in cognitively normal subjects-the ABIDE project
Ingrid S van Maurik, Rosalinde E R Slot, Sander C J Verfaillie, et al.
Journal of Alzheimer'S Disease : JAD
|
January 17, 2022
Psychosocial Effects of COVID-19 Measures on (Pre-)Dementia Patients During Second Lockdown
Els D Bakker, Ingrid S van Maurik, Arenda Mank, et al.
Brain : a Journal of Neurology
|
October 21, 2022
Social cognition deficits and biometric signatures in the behavioural variant of Alzheimer's disease
Ellen H Singleton, Jay L P Fieldhouse, Jochum J van 't Hooft, et al.
Neurobiology of Aging
|
April 27, 2019
Amyloid PET and cognitive decline in cognitively normal individuals: the SCIENCe project
Tessa Timmers, Rik Ossenkoppele, Sander C J Verfaillie, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
April 5, 2021
White matter microstructure disruption in early stage amyloid pathology
Lyduine E Collij, Silvia Ingala, Herwin Top, et al.
Alzheimer'S Research & Therapy
|
May 14, 2016
Bapineuzumab for mild to moderate Alzheimer's disease in two global, randomized, phase 3 trials
Rik Vandenberghe, Juha O Rinne, Mercè Boada, et al.
Page
of 91